Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis development.
Atherosclerotic disease is the leading cause of death world-wide. Our goal was to explore the effect of phytocannabinoids on the molecular mechanisms triggering the development of the atheromatous lesion. Three cannabis sativa extracts of different chemotypes were chemically characterized by UPLC-DA...
Saved in:
Main Authors: | Bruno Musetti, Alejandra Kun, David Menchaca, Alejandra Rodríguez-Haralambides, Javier Varela, Leonor Thomson, Edward M Bahnson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0310777 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LOX-1, OxLDL, and Atherosclerosis
by: Angela Pirillo, et al.
Published: (2013-01-01) -
Cannabigerol and cannabichromene in Cannabis sativa L.
by: Zagožen Marjeta, et al.
Published: (2021-09-01) -
Characterization of the Cannabis sativa glandular trichome epigenome
by: Lee J. Conneely, et al.
Published: (2024-11-01) -
Cannabis sativa Plant Identification and Its Look-Alikes
by: Cliff G. Martin, et al.
Published: (2024-05-01) -
Cannabis sativa subsp. sativa's pharmacological properties and health effects: A scoping review of current evidence.
by: Xin Yi Lim, et al.
Published: (2021-01-01)